Kumar Dinesh, Bhujbal S S, Deoda R S, Mudgade S C
Rayat Institute of Pharmacy, Railmajra, S.B.S. Nagar, Punjab, India.
Pharmacognosy Res. 2010 Mar;2(2):102-6. doi: 10.4103/0974-8490.62955.
Biologically active compounds from natural sources are of interest as possible new drugs for infectious diseases. Ailanthus excelsa Roxb. has been used in Indian system of medicine in the treatment of asthma, bronchitis, cold, colic pain, etc. Stem bark of A. excelsa Roxb. has been used as a decoction in traditional claims. So, our traditional claims enforced us to evaluate its bronchodilator activity. We have evaluated its bronchodilator activity in milk-induced leukocytosis and eosinophilia, clonidine-induced mast cell degranulation, bronchoalveolar lavage fluid (BALF), and lung histopathology models. The aqueous extract of stem bark in doses of 100, 200, 400 mg/kg showed significant activity.
天然来源的生物活性化合物作为治疗传染病的新型潜在药物备受关注。臭椿已被用于印度医学体系中治疗哮喘、支气管炎、感冒、绞痛等疾病。臭椿的茎皮在传统医学中一直被用作煎剂。因此,传统医学的说法促使我们评估其支气管扩张活性。我们在牛奶诱导的白细胞增多和嗜酸性粒细胞增多、可乐定诱导的肥大细胞脱颗粒、支气管肺泡灌洗液(BALF)和肺组织病理学模型中评估了其支气管扩张活性。茎皮水提取物剂量为100、200、400mg/kg时显示出显著活性。